Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Edit custom filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

93 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Angptl4 integrates dietary and microbial signals to disrupt gut barrier function in MASH.
Chua D, Low ZS, Kim JHS, Lee YH, Kiatbumrung R, Somnark P, Xu M, Shi Y, Kaushal G, Vos MIG, Mahadevan A, Hooi N, Raj M, Sviriaeva E, Cui B, Tan S, Kasahara K, Ho CL, Wahli W, Yew KC, Wong SH, Cheung C, Pal M, Zhang R, Chuaypen N, Tangkijvanich P, Cheng HS, Li L, Tan NS. Chua D, et al. Among authors: chuaypen n. Nat Commun. 2026 May 22. doi: 10.1038/s41467-026-72575-6. Online ahead of print. Nat Commun. 2026. PMID: 42173835 Free article.
Diabetes and risk of significant fibrosis in adults with HIV and metabolic dysfunction-associated steatotic liver disease: a prospective cohort study.
Han WM, Apornpong T, Chuaypen N, Aung TPP, Amornritvanich P, Hiranburana N, Lwin HMS, Hiransuthikul A, Kerr S, Tangkijvanich P, Avihingsanon A. Han WM, et al. Among authors: chuaypen n. J Antimicrob Chemother. 2026 Feb 2;81(3):dkag053. doi: 10.1093/jac/dkag053. J Antimicrob Chemother. 2026. PMID: 41710964 Free article.
Inference of antimicrobial resistance (AMR) from a whole genome database outperforming AMR gene detection.
Cholsaktrakool P, Kawang K, Sangpiromapichai N, Thongsuk P, Anuntakarun S, Kunadirek P, Chuaypen N, Nilgate S, Kueakulpattana N, Rirerm U, Chatsuwan T, Jauneikaite E, Davies F, Pratanwanich PN, Sriswasdi S, Nilaratanakul V. Cholsaktrakool P, et al. Among authors: chuaypen n. iScience. 2025 Jun 20;28(8):112962. doi: 10.1016/j.isci.2025.112962. eCollection 2025 Aug 15. iScience. 2025. PMID: 40686603 Free PMC article.
Characterization of gut dysbiosis and intestinal barrier dysfunction in patients with metabolic dysfunction-associated steatotic liver disease and chronic kidney disease: a comparative study.
Dissayabutra T, Chuaypen N, Somnark P, Boonkaew B, Udomkarnjananun S, Kittiskulnam P, Charoenchittang P, Prombutara P, Tangkijvanich P. Dissayabutra T, et al. Among authors: chuaypen n. Sci Rep. 2025 May 3;15(1):15481. doi: 10.1038/s41598-025-00237-6. Sci Rep. 2025. PMID: 40319096 Free PMC article.
Prediction of cccDNA dynamics in hepatitis B patients by a combination of serum surrogate markers.
Kim KS, Iwamoto M, Kitagawa K, Park H, Hayashi S, Tsukuda S, Matsui T, Atsukawa M, Matsuura K, Chuaypen N, Tangkijvanich P, Allweiss L, Nishiyama T, Nakamura N, Fujita Y, Kawakami E, Nakaoka S, Muramatsu M, Aihara K, Wakita T, Perelson AS, Dandri M, Watashi K, Iwami S, Tanaka Y. Kim KS, et al. Among authors: chuaypen n. PLoS Comput Biol. 2025 Jan 9;21(1):e1012615. doi: 10.1371/journal.pcbi.1012615. eCollection 2025 Jan. PLoS Comput Biol. 2025. PMID: 39787253 Free PMC article.
Sensitivity and specificity of Nanopore sequencing for detecting carbapenem and 3rd-generation cephalosporin-resistant Enterobacteriaceae in urine samples: Real-time simulation with public antimicrobial resistance gene database.
Kawang K, Thongsuk P, Cholsaktrakool P, Anuntakarun S, Kunadirek P, Chuaypen N, Nilgate S, Chatsuwan T, Nookaew I, Sangpiromapichai N, Nilaratanakul V. Kawang K, et al. Among authors: chuaypen n. Heliyon. 2024 Aug 5;10(16):e35816. doi: 10.1016/j.heliyon.2024.e35816. eCollection 2024 Aug 30. Heliyon. 2024. PMID: 39253247 Free PMC article.
CAIM: coverage-based analysis for identification of microbiome.
Acheampong DA, Jenjaroenpun P, Wongsurawat T, Kurilung A, Pomyen Y, Kandel S, Kunadirek P, Chuaypen N, Kusonmano K, Nookaew I. Acheampong DA, et al. Among authors: chuaypen n. Brief Bioinform. 2024 Jul 25;25(5):bbae424. doi: 10.1093/bib/bbae424. Brief Bioinform. 2024. PMID: 39222062 Free PMC article.
CAIM: Coverage-based Analysis for Identification of Microbiome.
Acheampong DA, Jenjaroenpun P, Wongsurawat T, Krulilung A, Pomyen Y, Kandel S, Kunadirek P, Chuaypen N, Kusonmano K, Nookaew I. Acheampong DA, et al. Among authors: chuaypen n. bioRxiv [Preprint]. 2024 May 15:2024.04.25.591018. doi: 10.1101/2024.04.25.591018. bioRxiv. 2024. Update in: Brief Bioinform. 2024 Jul 25;25(5):bbae424. doi: 10.1093/bib/bbae424. PMID: 38746391 Free PMC article. Updated. Preprint.
Binding characteristics of pyrrole-scaffold hepatitis B virus capsid inhibitors and identification of novel potent compounds.
Ruengsatra T, Meeprasert A, Rattanangkool E, Deesiri S, Srisa J, Udomnilobol U, Dunkoksung W, Chuaypen N, Kiatbumrung R, Tangkijvanich P, Vimolmangkang S, Pudhom K, Prueksaritanont T. Ruengsatra T, et al. Among authors: chuaypen n. RSC Adv. 2023 Oct 6;13(41):29004-29022. doi: 10.1039/d3ra04720b. eCollection 2023 Sep 26. RSC Adv. 2023. PMID: 37807973 Free PMC article.
meta-Ureidophenoxy-1,2,3-triazole hybrid as a novel scaffold for promising HepG2 hepatocellular carcinoma inhibitors: Synthesis, biological evaluation and molecular docking studies.
Limpachayaporn P, Nuchpun S, Sirirak J, Charoensuksai P, Wongprayoon P, Chuaypen N, Tangkijvanich P, Suksamrarn A. Limpachayaporn P, et al. Among authors: chuaypen n. Bioorg Med Chem. 2022 Nov 15;74:117048. doi: 10.1016/j.bmc.2022.117048. Epub 2022 Oct 7. Bioorg Med Chem. 2022. PMID: 36270111
The Design and Synthesis of a New Series of 1,2,3-Triazole-Cored Structures Tethering Aryl Urea and Their Highly Selective Cytotoxicity toward HepG2.
Oekchuae S, Sirirak J, Charoensuksai P, Wongprayoon P, Chuaypen N, Boonsombat J, Ruchirawat S, Tangkijvanich P, Suksamrarn A, Limpachayaporn P. Oekchuae S, et al. Among authors: chuaypen n. Pharmaceuticals (Basel). 2022 Apr 20;15(5):504. doi: 10.3390/ph15050504. Pharmaceuticals (Basel). 2022. PMID: 35631331 Free PMC article.
Identification of microRNA-96-5p as a postoperative, prognostic microRNA predictor in nonviral hepatocellular carcinoma.
Matsui T, Hamada-Tsutsumi S, Naito Y, Nojima M, Iio E, Tamori A, Kubo S, Ide T, Kondo Y, Eguchi Y, Komori A, Morine Y, Shimada M, Utsunomiya T, Shirabe K, Kimura K, Hiasa Y, Chuaypen N, Tangkijvanich P, Naiki-Ito A, Takahashi S, Ochiya T, Tanaka Y. Matsui T, et al. Among authors: chuaypen n. Hepatol Res. 2022 Jan;52(1):93-104. doi: 10.1111/hepr.13674. Epub 2021 Jun 14. Hepatol Res. 2022. PMID: 34038612
Genome-wide Association Study Identifies Genetic Variants Associated With Early and Sustained Response to (Pegylated) Interferon in Chronic Hepatitis B Patients: The GIANT-B Study.
Brouwer WP, Chan HLY, Lampertico P, Hou J, Tangkijvanich P, Reesink HW, Zhang W, Mangia A, Tanwandee T, Montalto G, Simon K, Ormeci N, Chen L, Tabak F, Gunsar F, Flisiak R, Ferenci P, Akdogan M, Akyuz F, Hirankarn N, Jansen L, Wong VW, Soffredini R, Liang X, Chen S, Groothuismink ZMA, Santoro R, Jaroszewicz J, Ozaras R, Kozbial K, Brahmania M, Xie Q, Chotiyaputta W, Xun Q, Pazgan-Simon M, Oztas E, Verhey E, Montanari NR, Sun J, Hansen BE, Boonstra A, Janssen HLA; GIANT-B Global Consortium. Brouwer WP, et al. Clin Infect Dis. 2019 Nov 13;69(11):1969-1979. doi: 10.1093/cid/ciz084. Clin Infect Dis. 2019. PMID: 30715261 Free PMC article.
Predictive role of serum HBsAg and HBcrAg kinetics in patients with HBeAg-negative chronic hepatitis B receiving pegylated interferon-based therapy.
Chuaypen N, Posuwan N, Chittmittraprap S, Hirankarn N, Treeprasertsuk S, Tanaka Y, Shinkai N, Poovorawan Y, Tangkijvanich P. Chuaypen N, et al. Clin Microbiol Infect. 2018 Mar;24(3):306.e7-306.e13. doi: 10.1016/j.cmi.2017.07.016. Epub 2017 Jul 24. Clin Microbiol Infect. 2018. PMID: 28750917 Free article. Clinical Trial.
Original Research: Analysis of hepatic microRNA alterations in response to hepatitis B virus infection and pegylated interferon alpha-2a treatment.
Jinato T, Chuaypen N, Poomipak W, Praianantathavorn K, Makkoch J, Kiatbumrung R, Jampoka K, Tangkijvanich P, Payungporn S. Jinato T, et al. Among authors: chuaypen n. Exp Biol Med (Maywood). 2016 Oct;241(16):1803-10. doi: 10.1177/1535370216647184. Epub 2016 May 4. Exp Biol Med (Maywood). 2016. PMID: 27190255 Free PMC article.
Single Nucleotide Polymorphisms in miR-149 (rs2292832) and miR-101-1 (rs7536540) Are Not Associated with Hepatocellular Carcinoma in Thai Patients with Hepatitis B Virus Infection.
Pratedrat P, Sopipong W, Makkoch J, Praianantathavorn K, Chuaypen N, Tangkijvanich P, Payungporn S. Pratedrat P, et al. Among authors: chuaypen n. Asian Pac J Cancer Prev. 2015;16(15):6457-61. doi: 10.7314/apjcp.2015.16.15.6457. Asian Pac J Cancer Prev. 2015. PMID: 26434859 Free article.
A randomized clinical trial of peginterferon alpha-2b with or without entecavir in patients with HBeAg-negative chronic hepatitis B: Role of host and viral factors associated with treatment response.
Tangkijvanich P, Chittmittraprap S, Poovorawan K, Limothai U, Khlaiphuengsin A, Chuaypen N, Wisedopas N, Poovorawan Y. Tangkijvanich P, et al. Among authors: chuaypen n. J Viral Hepat. 2016 Jun;23(6):427-38. doi: 10.1111/jvh.12467. Epub 2015 Sep 21. J Viral Hepat. 2016. PMID: 26387494 Clinical Trial.
Association of Single Nucleotide Polymorphism rs1053004 in Signal Transducer and Activator of Transcription 3 (STAT3) with Susceptibility to Hepatocellular Carcinoma in Thai Patients with Chronic Hepatitis B.
Chanthra N, Payungporn S, Chuaypen N, Pinjaroen N, Poovorawan Y, Tangkijvanich P. Chanthra N, et al. Among authors: chuaypen n. Asian Pac J Cancer Prev. 2015;16(12):5069-73. doi: 10.7314/apjcp.2015.16.12.5069. Asian Pac J Cancer Prev. 2015. PMID: 26163643 Free article.